A late cutaneous response in actively sensitized rats: A new method for evaluating the efficacy of antiallergic drugs

Journal of Pharmacological Sciences

Volumn 101, Issue 4, 2006, Pages 350-355

  Shishikura, Takashi ^a   Shito, Keiko ^a   Uchida, Mitsuhiro ^a   Inaba, Tsuneyoshi ^a  

^a MEIJI SEIKA KAISHA LTD   (Japan)

Author keywords

Allergy; Early phase response; Late phase response; Mast cell; T cell

Indexed keywords

ANTIALLERGIC AGENT; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; HAPTEN; OVALBUMIN; PERTUSSIS VACCINE;

ALLERGY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; MALE; MAST CELL; NONHUMAN; RAT; T LYMPHOCYTE;

EID: 33747822934     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0060519     Document Type: Article

References (28)

1. O'Byrne PM, Dolovich J, Hargreave FE. Late asthmatic responses. Am Rev Respir Dis. 1987;136:740-751.
2. Auty RM. The clinical development of a new agent for the treatment of airway inflammation, nedocromil sodium (Tilade). Eur J Respir Dis. 1986;147:120-131.
3. Garland LG, Hodson HF. Antiallergic drugs. In: Dale MM, Foreman JC, editors. Textbook of immunopharmacology. London: Blackwell Scientific Publications; 1984. p. 265-282.
4. Cockcroft DW, Murdock KY. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987;79:734-740.
5. Eisen HN, Belman S, Carsten ME. The reaction of 2,4-dinitrobenzensulfonic acid with free amino groups of proteins. J Am Chem Soc. 1953;75:4583-4585.
6. Tada T, Okumura K. Regulation of homocytotropic antibody formation in the rat. I. Feed-back regulation by passively administered antibody. J Immunol. 1971;106:1002-1011.
7. Pauwels R, Bazin H, Platteau B, Van Der Straeten M. Relation between total serum IgE levels and IgE antibody production in rats. Int Arch Allergy Appl Immun. 1979;58:351-357.
8. Marone G. Control mechanisms of mediator release in human basophils and mast cells. Immunol Invest. 1988;17:707-745.
9. White DJ. Cyclosporin A. Clinical pharmacology and therapeutic potential. Drugs. 1982;24:322-334.
10. Puignero V, Salgado J, Queralt J. Effects of cyclosporine and dexamethasone on IgE antibody response in mice, and on passive cutaneous anaphylaxis in the rat. Int Arch Allergy Immunol. 1995;108:142-147.
11. Picado C. Early and late-phase asthmatic reactions: a hypothesis. Allergy. 1992;47:331-333.
12. Dahl R. Early and late phase reactions in the bronchi and the nose. In: Mygind N, pipkorn U, Dahl R, editors. Rhinitis and asthma. Similarities and differences. Copenhagen: Munksgaard; 1990. p. 303-312.
13. Secrist H, DeKruyff RH, Umetsu D. Interleukin 4 production by CD4+ T cells from allergic indivisuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med. 1995;181:1081-1089.
14. Fukuda T, Akutsu I, Motojima S, Makino S. Inhibition of antigen-induced late asthmatic response and bronchial hyperresponsiveness by cyclosporine and FK506. Int Arch Allergy Appl Immunol. 1991;94:259-261.
15. Feldmann M, Male DK. Cell cooperation in the antibody response. In: Roitt IM, Brostoff J, Male DK, editors. Immunology. 2nd ed. London: Gower Medical Publishing; 1989. p. 8.1-8.12.
16. Barry WC, Ruddle NH. The delayed-type hypersensitivity response to (4-hydroxy-3-nitrophenyl)acetyl-(NP) coupled proteins is carrier-specific: in vivo and in vitro demonstrations. J Immunol. 1983;131:70-76.
17. Kapsenberg ML, Bos JD, Wierenga EA. T cells in allergic responses to haptens and proteins. Springer Semin Immunopathol. 1992;13:303-314.
18. Raff MC. Role of thymus-derived lymphocytes in the secondary humoral immune response in mice. Nature. 1970;226:1257-1258.
19. Shida T. [A comparison of the pharmacological actions between DSCG (disodium cromoglycate) and BDP (beclomethasone dipropionate) in the treatment of bronchial asthma.] Nippon Rinsho. 1996;54:3011-3016. (text in Japanese with English abstract)
20. Virchow JC Jr, Kroegel C, Walker C, Matthys H. Inflammatory determinants of asthma severity: mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma. J Allergy Clin Immunol. 1996;98:S27-S33.
21. Nagai H, Sakurai T, Inagaki N, Mori H. An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol Pharm Bull. 1995;18:239-245.
22. Morley J. PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. Agents Actions Suppl. 1987;21: 87-95.
23. Oh JW, Lee HB, Chung YH, Choi Y. The effect of disodium cromoglycate, budesonide, and cyclosporin A on interleukin-4, interleukin-5, and interleukin-13 secretions in Der p I-stimulated T cells from house dust mite-sensitive atopic and nonatopic individuals. Allergy Asthma Proc. 2002;23:109-115.
24. Kuriyama K, Hiyama Y, Nagatahira R, Okuda T, Saito K, Ito K. An antiallergic activity of disodium cromoglycate unrelated to mast cell activation. Agents Actions. 1986;18:473-478.
25. Shishikura T, Yamada M, Oguro K, Tamaki N, Kosugi T. Induction of airway hyperresponsiveness in allergic rats. Int J Tissue React. 1990;12:341-346.
26. Russi EW, Perruchoud AP, Yerger LD, Stevenson JS, Tabak J, Marchette B, et al. Late phase bronchial obstruction following nonimmunologic mast cell degranulation. J Appl Physiol. 1984;57:1182-1188.
27. Cieslewicz G, Tomkinson A, Adler A, Duez C, Schwarze J, Takeda K, et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. J Clin Invest. 1999;104:301-308.
28. Hansen I, Klimek L, Mosges R, Hormann K. Mediators of inflammation in the early and the late phase of allergic rhinitis. Curr Opin Allergy Clin Immunol. 2004;4:159-163.